Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis

Background The optimal use of induction therapy in low-immunological-risk kidney transplant recipients (KTRs) remains uncertain. While Basiliximab (BSX) is widely utilized, its comparative outcomes with no induction therapy require further evaluation.Method This single-center retrospective cohort st...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Dahao Zhang, Jiqiu Wen, Jianhui Dong, Rong Ma, Shijian Li, Jihua Wu, Ning Wen, Zhiying Lei, Haibin Li, Jun Yin, Xuyong Sun
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2025-12-01
Schriftenreihe:	Renal Failure
Schlagworte:	Kidney transplantation induction therapy no induction low-immunological-risk infection propensity score matching
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2460729
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!